Affinergy teams with Synthes
This article was originally published in The Gray Sheet
Executive Summary
"Biological glue" proprietor Affinergy and orthopedic device manker Synthes will collaborate on multiple product applications across the spine, trauma and craniomaxillofacial markets under a long-term development program announced Sept. 11. Affinergy's Interfacial Biomaterial coating process can reduce the risks of infection, friction and clotting associated with an orthopedic implant, and "provide for a much tighter integration of the actual device," the company says (1"The Gray Sheet" March 8, 2004, p. 26). The firm is interested in targeting the cardiovascular market as well...